Figure 4.
Tumor growth curves showing the in vivo antitumor effect of PHA-665752, vemurafenib, and a combination of the two. Tumor size was measured starting after 6 days and then once every 3 days. The LSD post hoc test was used for statistical analysis to compare differences between groups (n=10/group), *P<0.05. LSD, least significant difference.